Showing results 41 to 60 of 60
< previous
Issue Date | Title | Involved Person(s) |
2016 | Molecular recognition of the catalytic zinc(II) ion in MMP-13 : structure-based evolution of an allosteric inhibitor to dual binding mode inhibitors with improved lipophilic ligand efficiencies | Fischer, Thomas; Riedl, Rainer |
23-Jan-2021 | New perspectives in oral peptide delivery | Zizzari, Alessandra Tania; Pliatsika, Dimanthi; Gall, Flavio; Fischer, Thomas; Riedl, Rainer |
26-Jan-2023 | Novel antifungal compounds | Knechtle, Philipp; Gombert, Frank Otto; Riedl, Rainer; Lindenmann, Urs; Krebs, Walter, et al |
Feb-2022 | Paracelsus' legacy in the faunal realm : drugs deriving from animal toxins | Fischer, Thomas; Riedl, Rainer |
5-Oct-2018 | Primary resistance mechanism of the canine distemper virus fusion protein against a small-molecule membrane fusion inhibitor | Kalbermatter, David; Shrestha, Neeta; Ader-Ebert, Nadine; Herren, Michael; Moll, Pascal, et al |
2017 | Pseudouridimycin : das erste Nukleosid-Analogon, das bakterielle RNA-Polymerase selektiv inhibiert | Chellat, Mathieu F.; Riedl, Rainer |
2017 | Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase | Chellat, Mathieu F.; Riedl, Rainer |
19-Apr-2021 | Rücktitelbild: Antiprotozoische Struktur-Aktivitäts-Beziehungen von synthetischen Leucinostatin-Derivaten und Aufklärung ihres Wirkprinzips (Angew. Chem. 28/2021) | Brand, Michael; Wang, Lei; Agnello, Stefano; Gazzola, Silvia; Gall, Flavio M., et al |
2013 | Strategic targeting of multiple water-mediated interactions : a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors | Fischer, Thomas; Riedl, Rainer |
7-Feb-2023 | Structure and supramolecular organization of the canine distemper virus attachment glycoprotein | Kalbermatter, David; Jeckelmann, Jean-Marc; Wyss, Marianne; Shrestha, Neeta; Pliatsika, Dimanthi, et al |
1-Dec-2022 | Structure of a hydrophobic leucinostatin derivative determined by host lattice display | Kiss, Cedric; Gall, Flavio M.; Dreier, Birgit; Adams, Michael; Riedl, Rainer, et al |
30-May-2018 | Eine strukturelle Evaluierung medizinalchemischer Strategien gegen Wirkstoffresistenzen | Agnello, Stefano; Brand, Michael; Chellat, Mathieu; Gazzola, Silvia; Riedl, Rainer |
2017 | Targeted fluoro positioning for the discovery of a potent and highly selective matrix metalloproteinase inhibitor | Fischer, Thomas; Riedl, Rainer |
2017 | Targeted polypharmacology : discovery of a highly potent non-hydroxamate dual matrix metalloproteinase (MMP)-10/-13 inhibitor | Senn, Nicole; Ott, Michael; Lanz, Jan; Riedl, Rainer |
2016 | Targeting antibiotic resistance | Chellat, Mathieu F.; Raguž, Luka; Riedl, Rainer |
Mar-2010 | Thermal cleavage of the Fmoc protection group | Höck, Stefan; Marti, Roger; Riedl, Rainer; Simeunovic, Marina |
2021 | Tissue inhibitor of metalloproteinase (TIMP) peptidomimetic as an adjunctive therapy for infectious keratitis | Neidhart, Berna; Kowalska, Malwina; Valentin, Jules D. P.; Gall, Flavio; Ren, Qun, et al |
18-Feb-2019 | Titelbild: Von der Natur inspiriertes Wirkstoffdesign : kristallographische Detektion eines selbstgenerierten Inhibitor‐Grundgerüsts (Angew. Chem. 12/2019) | Gall, Flavio M.; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E., et al |
11-Aug-2022 | Treatment of skin disorders | Adams, Michael; Kemmler, Michael; Riedl, Rainer; Pliatsika, Dimanthi; Imanidis, Georgios, et al |
7-Jan-2019 | Von der Natur inspiriertes Wirkstoffdesign : kristallographische Detektion eines selbstgenerierten Inhibitor‐Grundgerüsts | Gall, Flavio; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E., et al |